Terms: = Lung cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Prognosis
331 results:
1. Prognostic Implications of Small Cell lung cancer Transcriptional Subtyping for CNS Metastases.
Tringale KR; Skakodub A; Egger J; Eichholz J; Yu Y; Gomez D; Rimner A; Li B; Yamada Y; Wilcox J; Moss N; Imber BS; Rekhtman N; Baine MK; Rudin CM; Pike LRG
JCO Precis Oncol; 2024 Apr; 8():e2300470. PubMed ID: 38691815
[TBL] [Abstract] [Full Text] [Related]
2. Cell-Free DNA 5-Hydroxymethylcytosine Signatures for lung cancer prognosis.
Shao J; Olsen RJ; Kasparian S; He C; Bernicker EH; Li Z
Cells; 2024 Feb; 13(4):. PubMed ID: 38391911
[TBL] [Abstract] [Full Text] [Related]
3. Pan-cancer analyses of bromodomain containing 9 as a novel therapeutic target reveals its diagnostic, prognostic potential and biological mechanism in human tumours.
Chen Y; Gao Z; Mohd-Ibrahim I; Yang H; Wu L; Fu Y; Deng Y
Clin Transl Med; 2024 Feb; 14(2):e1543. PubMed ID: 38303608
[TBL] [Abstract] [Full Text] [Related]
4. Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors.
Cook S; Samuel V; Meyers DE; Stukalin I; Litt I; Sangha R; Morris DG; Heng DYC; Pabani A; Dean M; Navani V
JAMA Netw Open; 2024 Jan; 7(1):e2352302. PubMed ID: 38236598
[TBL] [Abstract] [Full Text] [Related]
5. CT Predictors of Visceral Pleural Invasion in Patients with Non-Small Cell lung cancers 30 mm or Smaller.
Sun Q; Li P; Zhang J; Yip R; Zhu Y; Yankelevitz DF; Henschke CI
Radiology; 2024 Jan; 310(1):e231611. PubMed ID: 38193838
[TBL] [Abstract] [Full Text] [Related]
6. Variant allele frequency in circulating tumor DNA correlated with tumor disease burden and predicted outcomes in patients with advanced breast cancer.
Zhong J; Jiang H; Liu X; Liao H; Xie F; Shao B; Jia S; Li H
Breast Cancer Res Treat; 2024 Apr; 204(3):617-629. PubMed ID: 38183515
[TBL] [Abstract] [Full Text] [Related]
7. lung and blood perioperative metalloproteinases in patients undergoing oncologic lung surgery: Prognostic implications.
Alonso A; de la Gala F; Vara E; Hortal J; Piñeiro P; Reyes A; Simón C; Garutti I
Thorac Cancer; 2024 Feb; 15(4):307-315. PubMed ID: 38155459
[TBL] [Abstract] [Full Text] [Related]
8. Association of Geriatric Nutritional Risk Index With Immune Checkpoint Inhibitor Treatment Duration and Adverse Events in lung cancer.
Shimizu A; Fukasawa M; Mitani K; Goto K; Wakamoto A; Hatsuyama T; Hoshi T; Hasegawa I; Sato H
In Vivo; 2024; 38(1):418-424. PubMed ID: 38148096
[TBL] [Abstract] [Full Text] [Related]
9. Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal cancer after Treatment Termination.
Simmons K; Thomas JV; Ludford K; Willis JA; Higbie VS; Raghav KPS; Johnson B; Dasari A; Kee BK; Parseghian CM; Lee MS; Le PH; Morelli MP; Shen JP; Bent A; Vilar E; Wolff RA; Kopetz S; Overman MJ; Morris VK
Cancer Res Commun; 2023 Dec; 3(12):2510-2517. PubMed ID: 38085001
[TBL] [Abstract] [Full Text] [Related]
10. Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial.
Desai J; Alonso G; Kim SH; Cervantes A; Karasic T; Medina L; Shacham-Shmueli E; Cosman R; Falcon A; Gort E; Guren T; Massarelli E; Miller WH; Paz-Ares L; Prenen H; Amatu A; Cremolini C; Kim TW; Moreno V; Ou SI; Passardi A; Sacher A; Santoro A; Stec R; Ulahannan S; Arbour K; Lorusso P; Luo J; Patel MR; Choi Y; Shi Z; Mandlekar S; Lin MT; Royer-Joo S; Chang J; Jun T; Dharia NV; Schutzman JL; ; Han SW
Nat Med; 2024 Jan; 30(1):271-278. PubMed ID: 38052910
[TBL] [Abstract] [Full Text] [Related]
11. Heart failure 'the cancer of the heart': the prognostic role of the HLM score.
Severino P; Mancone M; D'Amato A; Mariani MV; Prosperi S; Alunni Fegatelli D; Birtolo LI; Angotti D; Milanese A; Cerrato E; Maestrini V; Pizzi C; Foà A; Vestri A; Palazzuoli A; Vizza CD; Casale PN; Mather PJ; Fedele F
ESC Heart Fail; 2024 Feb; 11(1):390-399. PubMed ID: 38011913
[TBL] [Abstract] [Full Text] [Related]
12. A Phase II Study of High-Flow Nasal Cannula for Relieving Dyspnea in Advanced cancer Patients.
Takase E; Akamatsu H; Teraoka S; Nakaguchi K; Tanaka M; Kaki T; Furuta K; Sato K; Murakami E; Sugimoto T; Shibaki R; Fujimoto D; Hayata A; Tokudome N; Ozawa Y; Koh Y; Nakanishi M; Kanai K; Shimokawa T; Yamamoto N
J Pain Symptom Manage; 2024 Mar; 67(3):204-211.e1. PubMed ID: 37992848
[TBL] [Abstract] [Full Text] [Related]
13. Social vulnerability and lung malignancy mortality.
Ibrahim R; Sakr L; Lewis JA; Kim RY; Benn BS; Low SW
J Cancer Policy; 2023 Dec; 38():100453. PubMed ID: 37977216
[TBL] [Abstract] [Full Text] [Related]
14. Comparison of gene mutation profile in different lung adenocarcinoma subtypes by targeted next-generation sequencing.
Zhang S; Dong P; Pan Z; Chen Q; Zhu J; Mao Z
Med Oncol; 2023 Nov; 40(12):349. PubMed ID: 37935925
[TBL] [Abstract] [Full Text] [Related]
15. Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
Augustin RC; Newman S; Li A; Joy M; Lyons M; Pham MP; Lucas P; Smith K; Sander C; Isett B; Davar D; Najjar YG; Zarour HM; Kirkwood JM; Luke JJ; Bao R
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857525
[TBL] [Abstract] [Full Text] [Related]
16. Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis.
Murthy HS; Zhang MJ; Chen K; Ahmed S; Deotare U; Ganguly S; Kansagra A; Michelis FV; Nishihori T; Patnaik M; Abid MB; Aljurf M; Arai Y; Bacher U; Badar T; Badawy SM; Ballen K; Battiwalla M; Beitinjaneh A; Bejanyan N; Bhatt VR; Brown VI; Martino R; Cahn JY; Castillo P; Cerny J; Chhabra S; Copelan E; Daly A; Dholaria B; Diaz Perez MA; Freytes CO; Grunwald MR; Hashmi S; Hildebrandt GC; Jamy O; Joseph J; Kanakry CG; Khera N; Krem MM; Kuwatsuka Y; Lazarus HM; Lekakis LJ; Liu H; Modi D; Munshi PN; Mussetti A; Palmisiano N; Patel SS; Rizzieri DA; Seo S; Shah MV; Sharma A; Sohl M; Solomon SR; Ulrickson M; Ustun C; van der Poel M; Verdonck LF; Wagner JL; Wang T; Wirk B; Zeidan A; Litzow M; Kebriaei P; Hourigan CS; Weisdorf DJ; Saber W; Kharfan-Dabaja MA
Blood Adv; 2023 Nov; 7(22):7007-7016. PubMed ID: 37792849
[TBL] [Abstract] [Full Text] [Related]
17. Integrated analysis of phase 1a and 1b randomized controlled trials; Treg-targeted cancer immunotherapy with the humanized anti-CCR4 antibody, KW-0761, for advanced solid tumors.
Fujikawa K; Saito T; Kurose K; Kojima T; Funakoshi T; Sato E; Kakimi K; Iida S; Doki Y; Oka M; Ueda R; Wada H
PLoS One; 2023; 18(9):e0291772. PubMed ID: 37729184
[TBL] [Abstract] [Full Text] [Related]
18. Immuno-PET of colorectal cancer with a CEA-targeted [68 Ga]Ga-nanobody: from bench to bedside.
Li L; Lin X; Wang L; Ma X; Zeng Z; Liu F; Jia B; Zhu H; Wu A; Yang Z
Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3735-3749. PubMed ID: 37382662
[TBL] [Abstract] [Full Text] [Related]
19. De Novo and Histologically Transformed Small-Cell lung cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways.
Chakraborty S; Coleman C; Manoj P; Demircioglu D; Shah N; de Stanchina E; Rudin CM; Hasson D; Sen T
Clin Cancer Res; 2023 Sep; 29(17):3526-3540. PubMed ID: 37382635
[TBL] [Abstract] [Full Text] [Related]
20. A 20-gene mutation signature predicts the efficacy of immune checkpoint inhibitor therapy in advanced non-small cell lung cancer patients.
Hu X; Guo J; Shi J; Li D; Li X; Zhao W
BMC Pulm Med; 2023 Jun; 23(1):223. PubMed ID: 37349743
[TBL] [Abstract] [Full Text] [Related]
[Next]
